The discovery of anti-PLA2R Ab [5] in the serum of primary MGN patients and anti-THSD7A Ab [6] among primary MGN variants who are seronegative for anti-PLA2R Ab changes the dimension of diagnosis monitoring of patients using different techniques like western blot, recombinant immunofluorescence, enzyme-linked immunosorbent assay (ELISA) and many others [7]. Here, PLA2R1 is linked to idiopathic membranous glomerulonephritis.